Cas no 2306263-02-3 (tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate)
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- 1-Piperidinecarboxylic acid, 4-(hydroxy-4-piperidinylmethyl)-, 1,1-dimethylethyl ester
- tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate
-
- MDL: MFCD33550500
- Inchi: 1S/C16H30N2O3/c1-16(2,3)21-15(20)18-10-6-13(7-11-18)14(19)12-4-8-17-9-5-12/h12-14,17,19H,4-11H2,1-3H3
- InChI Key: SSVUSTRGFAPXRX-UHFFFAOYSA-N
- SMILES: N1(C(OC(C)(C)C)=O)CCC(C(O)C2CCNCC2)CC1
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBWB100288-100MG |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 100MG |
¥ 2,211.00 | 2023-03-07 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBWB100288-250MG |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 250MG |
¥ 3,537.00 | 2023-03-07 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBWB100288-500MG |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 500MG |
¥ 5,887.00 | 2023-03-07 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBWB100288-1G |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 1g |
¥ 8,830.00 | 2023-03-07 | |
| NAN JING YAO SHI KE JI GU FEN Co., Ltd. | PBWB100288-5G |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 5g |
¥ 26,492.00 | 2023-03-07 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1564252-100mg |
Tert-butyl 4-(hydroxy(piperidin-4-yl)methyl)piperidine-1-carboxylate |
2306263-02-3 | 98% | 100mg |
¥8827 | 2023-03-19 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1564252-250mg |
Tert-butyl 4-(hydroxy(piperidin-4-yl)methyl)piperidine-1-carboxylate |
2306263-02-3 | 98% | 250mg |
¥11481 | 2023-03-19 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1564252-500mg |
Tert-butyl 4-(hydroxy(piperidin-4-yl)methyl)piperidine-1-carboxylate |
2306263-02-3 | 98% | 500mg |
¥14124 | 2023-03-19 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1564252-1g |
Tert-butyl 4-(hydroxy(piperidin-4-yl)methyl)piperidine-1-carboxylate |
2306263-02-3 | 98% | 1g |
¥22075 | 2023-03-19 | |
| Enamine | EN300-27149824-0.05g |
tert-butyl 4-[hydroxy(piperidin-4-yl)methyl]piperidine-1-carboxylate |
2306263-02-3 | 95% | 0.05g |
$285.0 | 2023-09-11 |
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate Related Literature
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
Additional information on tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate
tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate (CAS No. 2306263-02-3)
The compound tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate, identified by the CAS registry number 2306263-02-3, is a complex organic molecule with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of piperidine derivatives, which have been extensively studied due to their unique structural properties and biological activities. The molecule features a piperidine ring system, a hydroxymethyl group, and a tert-butyl ester moiety, making it a versatile structure for further functionalization and exploration in drug discovery.
Recent advancements in synthetic chemistry have enabled the efficient synthesis of tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate through multi-step reactions involving ring-forming techniques and esterification processes. Researchers have demonstrated that the compound can be synthesized via a combination of nucleophilic substitution and cyclization reactions, leveraging the reactivity of piperidine derivatives. The tert-butyl ester group plays a crucial role in stabilizing the molecule during synthesis, ensuring high yields and purity.
From a pharmacological perspective, tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate has shown promising results in preliminary studies. Its piperidine backbone is known to exhibit bioactivity in various biological systems, particularly in modulating enzyme activities and receptor interactions. Recent studies have highlighted its potential as a lead compound for the development of novel therapeutic agents targeting central nervous system disorders, such as anxiety and depression. The hydroxymethyl group attached to the piperidine ring introduces additional hydrogen bonding capabilities, enhancing its ability to interact with biological targets.
In terms of structural analysis, the molecule's tert-butyl ester group contributes significantly to its lipophilicity, which is critical for drug absorption and bioavailability. Computational modeling studies have revealed that tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate exhibits favorable pharmacokinetic properties, including moderate solubility and permeability. These attributes make it an attractive candidate for further preclinical testing.
Moreover, the compound's unique structure has inspired researchers to explore its applications in materials science. The piperidine ring system can serve as a building block for constructing advanced materials with tailored mechanical and electronic properties. For instance, recent research has focused on incorporating this compound into polymer networks to enhance their thermal stability and mechanical strength.
Despite its potential, further investigations are required to fully elucidate the biological mechanisms and safety profiles of tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate. Collaborative efforts between chemists, biologists, and pharmacologists are essential to unlock its full potential across diverse fields.
2306263-02-3 (tert-butyl 4-[hydroxy(4-piperidyl)methyl]piperidine-1-carboxylate) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)